The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression

I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany)

Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Session: Novel mechanisms and management of paediatric asthma
Session type: E-poster session
Number: 1220
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Ricklefs (Luebeck, Germany), L. Schäfer (Luebeck, Germany), N. Weissheimer (Luebeck, Germany), M. Weckmann (Luebeck, Germany), D. Thiele (Luebeck, Germany), I. König (Luebeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hanover, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Luebeck, Germany). The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression. 1220

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: